VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 37 filers reported holding VERONA PHARMA PLC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 59 | +1.7% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 58 | -50.4% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 117 | -73.5% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 442 | +18.2% | 0.00% | – |
| Q3 2019 | $1,000 | -98.1% | 374 | -96.4% | 0.00% | – |
| Q2 2019 | $52,000 | -30.7% | 10,274 | -12.0% | 0.00% | – |
| Q1 2019 | $75,000 | +36.4% | 11,674 | +89.1% | 0.00% | – |
| Q4 2018 | $55,000 | -65.6% | 6,174 | -51.9% | 0.00% | – |
| Q3 2018 | $160,000 | -9.1% | 12,834 | -0.8% | 0.00% | – |
| Q2 2018 | $176,000 | +417.6% | 12,934 | +660.4% | 0.00% | – |
| Q1 2018 | $34,000 | +385.7% | 1,701 | +183.5% | 0.00% | – |
| Q4 2017 | $7,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |